Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7700081 | GALDERMA LABS | Foaming compositions for hair care |
Jan, 2022
(1 year, 1 month ago) |
Market Authorisation Date: 05 February, 2004
Treatment: Topical treatment of scalp psoriasis
Dosage: SHAMPOO;TOPICAL
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9956231 | PRIMUS PHARMS | Topical formulations comprising a steroid |
Aug, 2030
(7 years from now) | |
US10064875 | PRIMUS PHARMS | Topical formulations comprising a steroid |
Aug, 2030
(7 years from now) | |
US10588914 | PRIMUS PHARMS | Topical formulations comprising a steroid |
Aug, 2030
(7 years from now) | |
US9855334 | PRIMUS PHARMS | Topical compositions comprising a corticosteroid |
Mar, 2035
(12 years from now) |
Market Authorisation Date: 28 November, 2017
Treatment: Treatment of moderate plaque psoriasis; Treatment of plaque psoriasis in patients 18 years of age or older; Psoriasis; Twice daily topical treatment of moderate to severe plaque psoriasis.; Treatment of plaque psoriasis; Plaque psoriasis; Treatment of moderate to severe plaque psoriasis in patients 18 years of age or older
Dosage: CREAM;TOPICAL
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8962000 | MYLAN | Microemulsion and sub-micron emulsion process and compositions |
Aug, 2025
(2 years from now) | |
US8460641 | MYLAN | Microemulsion process and composition |
Nov, 2028
(5 years from now) |
Market Authorisation Date: 12 January, 2007
Treatment: Treatment of corticosteroid-responsive dermatoses
Dosage: AEROSOL, FOAM;TOPICAL
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic